WHIPPANY, N.J.– Bayer, one of the country’s leading life-sciences companies, today announced changes to its U.S. Country Leadership Team.
Dave Tomasi will be the President, Consumer Health North America (CH NA), effective July 1. Dave, who has been serving as the Chief Commercial Officer for CH NA, joined Bayer in 2019, holding leadership roles in the Consumer Health division, most recently guiding strategy and operations across all functions, including portfolio management, retail strategy integration and commercial operations. Dave played a key role in the turnaround of the CH NA business over the past four years, driving operational excellence, financial performance, innovation, and strengthening the North America retail business. Dave is a leader with deep experience building high-performing organizations, developing growth strategies and highly successful market plans that deliver outstanding results, including helping guide CH NA to the €2.5 billion business it is today.
Dave is an active leader in Bayer. He is a graduate of West Point, a proud Veteran of the U.S. Army and continues to serve Veterans through his role as Executive Sponsor of the BRAVE Business Resource Group. He also serves on the board of BAYPAC, Bayer’s Employee Political Action Committee, as well as the Bayer Fund, the philanthropic arm of Bayer in the United States. Dave also serves on the Executive Board for the Consumer Health Products Association.
Prior to joining Bayer, Dave spent more than 20 years at Procter & Gamble in a number of leadership roles spanning personal health care, consumer products and retailer partnerships.
Dave replaces Patrick Lockwood-Taylor, President, Bayer U.S. & President, Consumer Health North America, who is leaving the company to accept a role as Chief Executive Officer at a health and wellness company. His last day with Bayer is June 29.
The Bayer U.S. President will be named in the future.
“With the appointment of Dave Tomasi as Consumer Health President NA, we have a seasoned leader with deep knowledge or our industry and customers,” said Heiko Schipper President, Consumer Health Division and Member, Bayer Board of Management. “I look forward to seeing our North America Consumer Health business continue to thrive and deliver the innovation consumers need. We thank Patrick for his outstanding leadership in both Consumer Health and as President of the U.S. business and wish him all the best as he pursues this new opportunity and continues the important work of advancing health and wellness.”
Guru Ramamurthy has been appointed Bayer U.S. Chief Financial Officer (CFO), effective July 1, filling an open role on the U.S. Country Leadership Team. Guru has been with Bayer for 22 years, most recently serving as Chief Financial Officer of Asklepios Biopharmaceuticals Inc. (AskBio) since 2021, an independently operated, fully-owned subsidiary of Bayer. Guru will continue to serve as AskBio CFO, working in this dual role until the end of the year. He has held multiple financial leadership roles at Bayer, including serving as Global Finance Lead for Global Oncology CFO of CH NA, CFO Bayer Medical Care, Head of Corporate Controlling for Bayer Pharmaceuticals, Global Finance Lead for Hematology & Cardiology among other roles.
Asha Hope has joined Bayer as the company’s Vice President and Head, North America Diversity, Equity & Inclusion. In this new U.S. Country Leadership Team role, Hope is responsible for driving sustainable change across Bayer by infusing diversity, equity & inclusion (DE&I) in the company’s business processes. She also works to ensure Bayer develops, retains, and attracts talent, supports an inclusive workplace and tracks and shares progress in DE&I focus areas. Hope previously held DE&I leadership positions at several industry-leading organizations, including, most recently, at DoorDash where she served as the Global Head of DE&I. Prior to that, she served as Global Head of DE&I for the International Consumer Business at Amazon, and held leadership roles at Macy’s and Coca-Cola.
“Our talented and seasoned leaders on the U.S. Country leadership team will continue to guide our U.S. business and drive innovation, bringing experience and insights to the team that will make our business stronger and enable us to continue to support our customers, patients, consumers and growers while accelerating growth for Bayer,” said Wolfgang Nickl, CFO and member of the Bayer Board of Management.
